Andor Revolution DSD now supported by Metamorph NX
February 16, 2012
Belfast, Andor Technology plc (Andor), a world leader in scientific imaging, spectroscopy solutions and confocal systems, today announced that they have come together with Molecular Devices to combine the latest in confocal imaging technology and software platforms, for the ultimate user experience. Andor’s Revolution DSD is a simple confocal imaging unit that can be fitted [...]
February 16, 2012
WALTHAM, Mass., PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Rutgers University Cell and DNA Repository (RUCDR), the largest cell and DNA biobank in the United States, has adopted the Company’s technologies for automation of Next Generation Sequencing (NGS) sample preparation. Next [...]
OSI Systems Receives $15 Million Contract from World Trade Center for Cargo and Parcel Screening
February 16, 2012
HAWTHORNE, Calif., OSI Systems, Inc. (NASDAQ: OSIS), a vertically-integrated provider of specialized electronics and services, today announced that its Security division, Rapiscan Systems, has been awarded a contract by the Port Authority of New York and New Jersey to provide cargo and parcel screening operations for the new World Trade Center. Under the $15 million [...]
NANOINK EXPANDS TIP-BASED LITHOGRAPHY PORTFOLIO WITH FIVE NEW EXCLUSIVE LICENSES
February 16, 2012
CHICAGO, NanoInk announced today that it entered into license agreements with Northwestern University that grant NanoInk exclusive commercial access to five new technologies for use in connection with tip-based lithography. The licensed technologies are Polymer Pen Lithography technology (also known as PPL technology); block co-polymer assisted nanolithography; force feedback leveling of massively parallel polymer pen [...]
ELISA Microplates for Diagnostic and Immunological Research
February 16, 2012
Porvair Sciences has announced a new range of high performance 96- well ELISA microplates for diagnostic and immunological research applications. Available with a choice of surface binding coatings an optimised Porvair ELISA microplate can be supplied for most applications. Manufactured from virgin USP Class VI crystal polystyrene - Porvair ELISA plates ensure excellent results with [...]
February 16, 2012
SAN DIEGO,Illumina, Inc. announced today that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued a Claim Construction Order in the litigation brought by Illumina against Complete Genomics, Inc. Illumina has accused Complete Genomics of infringing U.S. Patent No. 6,306,597. Judge Laporte’s February 8 Order provides the [...]
February 15, 2012
SAN JOSE, Calif., Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Thermo Scientific mass spectrometers continue to power breakthroughs in proteomics research as evidenced by recent publications in the prestigious journals Nature and Nature Methods. The unique capabilities of Thermo Scientific mass spectrometer systems played pivotal roles in 13 high-impact [...]
Highly Efficient Yeast Protoplast Production
February 15, 2012
AMSBIO is the global supplier of Zymolyase, a lytic enzyme mix for the digestion of yeast and fungal cell walls offering superior and broad based biological activity across many genera of fungi. In independent tests**, compared to Lyticase and Glusulase, Zymolyase generated yeast protoplasts more efficiently while not hindering regeneration into viable cells. Delivering higher [...]
TA Instruments Acquires BÄHR Thermoanalyse GmbH
February 15, 2012
New Castle, Delaware, USA — TA Instruments today announced the acquisition of BÄHR Thermoanalyse GmbH (Hüllhorst, Germany), a privately held manufacturer of high performance, high temperature thermal analysis systems. Commenting on the acquisition, Terry Kelly, President of TA Instruments said, “This acquisition adds powerful technologies which complement TA Instruments’ market leading thermal analysis product line. [...]
OGT develops optimised rare disease sequencing and analysis service
February 15, 2012
Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house [...]
